Category:

Pandemic

Latest

Provide price capping waiver, indemnity for Moderna’s single-dose Covid-19 vaccine: Cipla to Govt

Requesting the government to provide confirmation on four critical points — exemption from price restriction, indemnification, bridging trial waiver and basic customs duty exemption,

Cipla has said such an assurance will help make this significant financial commitment of more than USD 1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India, sources privy to the development said.

read more

UK in early stages of 3rd wave of coronavirus, warns Indian-origin scientist

Professor Ravi Gupta of the University of Cambridge, who is a member of the government’s New and Emerging Respiratory Virus Threats Advisory Group (Nervtag), said although new cases were “relatively low” the B.1.617 variant of the COVID-19 had fuelled “exponential growth”, the BBC reported.

On Sunday, the UK reported more than 3,000 new COVID infections for a fifth day in a row. Prior to this, the UK had not surpassed that number since April 12.

read more

India’s active COVID caseload below 20-lakh mark, 1,27,510 new cases reported

India recorded nearly 90.3 lakh Covid cases in May, by far the highest monthly count reported in any country so far. Although infections steadily declined through the second half of the month, the numbers overall were so high that the case count in May was 30% higher than the previous record of 69.4 lakh, also reported in India in the month of April.

read more

COVID impact: Digital recruitment process to continue, say experts

There was a rush towards new-age technology-aided recruitment/HR tools in 2020, amid the COVID-19 pandemic and new-age recruitment tools will continue to be leveraged extensively and increasingly in the future too.

“Corporates want to have data-based and analysis-driven inputs to make recruitment decisions and they employ various modern tools to ensure candidates cultural and job role fitment,” said Siddhartha Gupta, CEO, Mercer – Mettl.

read more

‘Covid-19 has no credible natural ancestor’: Explosive study claims Chinese scientists created virus in lab

The new research claims that scientists took a natural coronavirus “backbone” found in Chinese cave bats and spliced onto it a new “spike”, turning it into the deadly and highly transmissible Covid-19.

The paper also quotes that researchers found “unique fingerprints” in Covid-19 samples that they say could only have arisen from manipulation in a laboratory.Authors Dalgleish and Sorensen wrote in their paper that they had prima facie evidence of retro-engineering in China’ for a year, but were ignored by academics and major journals, reported DailyMail.com.

read more